Associate Director, Clinical Scientist
Travere Therapeutics
Summary
The Associate Director, Clinical Science, supports Travere's ongoing and future clinical development and life-cycle activities. Working with cross-functional study teams, this role contributes to clinical trial design and execution, translational and clinical data analyses, and the interpretation and presentation of results. The Associate Director coordinates assigned clinical science deliverables and helps ensure that studies are conducted in accordance with Good Clinical Practice (GCP).
Job description
Position Summary
The Associate Director, Clinical Science, supports Travere's ongoing and future clinical development and life-cycle activities. Working with cross-functional study teams, this role contributes to clinical trial design and execution, translational and clinical data analyses, and the interpretation and presentation of results. The Associate Director coordinates assigned clinical science deliverables and helps ensure that studies are conducted in accordance with Good Clinical Practice (GCP).
Responsibilities
- Lead clinical science components of assigned study plans and contribute to protocol design and implementation, including human pharmacology studies, and associated data analyses.
- Review, interpret, summarize clinical trial safety and efficacy data; identify findings and questions for discussion with the clinical development team.
- Coordinate assigned clinical science activities, timelines, and deliverables across study teams, maintaining accurate and well-organized documentation.
- Support study conduct in accordance with protocols, applicable regulations, and Good Clinical Practice (GCP).
- Lead the preparation and scientific review of clinical and data analysis reports, slide presentations, and ClinicalTrials.gov summaries in collaboration with clinical development, clinical pharmacology, statistics, and internal and external partners.
- Contribute clinical, scientific, and mechanism-of-action content to INDs, NDAs, BLAs, and related submissions, including protocols, statistical analysis plans, mock tables, figures, and listings, investigator brochures, medical reports, efficacy and safety summaries, scientific rationales, benefit-risk assessments, regulatory briefing books, and responses to regulator requests.
- Build and maintain productive working relationships and represent the clinical science team with alliance partners, external companies, investigators, and key opinion leaders in support of assigned clinical activities and collaborations.
- Contribute to manuscripts for scientific and medical journals and to presentations at scientific meetings.
- Additional duties assigned as needed.
Education/Experience Requirements
- PhD, PharmD, or MD in a related life science discipline required. Equivalent combination of education and applicable job experience may be considered.
- 4+ years of relevant experience in the pharmaceutical industry required; experience in rare disease preferred.
- Experience supporting clinical trials and clinical studies required; experience with human pharmacology studies preferred.
Additional Skills/Experience/Requirements
- The ideal candidate will embody Travere's core values: Courage, Community Spirit, Patient Focus and Teamwork.
- Driven, intelligent, passionate about making a difference for patients with rare diseases.
- Experience contributing to INDs, NDAs, BLAs, or regulatory information requests preferred.
- Experience across range of development phases.
- Ability to collaborate effectively in multidisciplinary teams and contribute to respectful, open discussion and creative problem solving.
- Ability to review, interpret, summarize, and present complex scientific and clinical data.
- Strong organizational skills and ability to prioritize multiple responsibilities in a dynamic, cross-functional environment.
- Attention to detail and ability to follow through on assigned work while managing changes in scope or timelines.
- Strong interpersonal, written, and verbal communication skills.
- Flexibility to adapt to changes in project plans and implement agreed strategies and tactics.
- Self-motivated and can independently manage responsibilities.
- Ability to travel domestically and internationally as needed (up to 15%).
Requirements
- PhD, PharmD, or MD in a related life science discipline required
- 4+ years of relevant experience in the pharmaceutical industry required
- Experience supporting clinical trials and clinical studies required
- Experience in rare disease preferred
- Experience with human pharmacology studies preferred
- Experience contributing to INDs, NDAs, BLAs, or regulatory information requests preferred
- Experience across range of development phases
- Ability to collaborate effectively in multidisciplinary teams
- Ability to review, interpret, summarize, and present complex scientific and clinical data
- Strong organizational skills and ability to prioritize multiple responsibilities
- Attention to detail and ability to follow through on assigned work
- Strong interpersonal, written, and verbal communication skills
- Flexibility to adapt to changes in project plans
- Self-motivated and can independently manage responsibilities
- Ability to travel domestically and internationally as needed (up to 15%)
Benefits
- Health insurance
- Financial offerings
- Work-life balance programs
- Well-being offerings
- Wellness programs
- Employee support programs
- Life insurance
- Disability insurance
- Retirement plans
- Employer match
- Paid time off
- Short-term incentive
- Long-term incentive compensation
- Company stock
Company overview
Travere Therapeutics is a biopharmaceutical company headquartered in San Diego, California, dedicated to identifying, developing, and delivering life-changing therapies for people living with rare kidney and metabolic diseases. Founded in 2011 as Retrophin and rebranded as Travere Therapeutics in 2020, the company has established itself as a leader in rare disease therapeutics with a focused pipeline targeting conditions with significant unmet medical needs. Their flagship product, FILSPARI® (sparsentan), received full FDA approval in September 2024 to slow kidney function decline in adults with primary IgA nephropathy (IgAN) who are at risk for disease progression. The company also has a Phase 3 clinical program for pegtibatinase (TVT-058) targeting classical homocystinuria (HCU), a rare genetic metabolic disorder. Travere maintains a commercial portfolio including Thiola EC® and Thiola® for cystinuria, demonstrating their commitment to serving rare disease communities through comprehensive therapeutic solutions. With a global presence and strategic partnerships, Travere Therapeutics continues to advance innovative treatments while supporting patient access and education initiatives for rare disease populations.